跳转至内容
Merck
CN
所有图片(1)

文件

安全信息

MIRAP00360

Sigma-Aldrich

MystiCq® microRNA qPCR Assay Primer

hsa-miR-375

登录查看公司和协议定价
所有图片(1)
UNSPSC代码:
41106308
miRNA ID:
hsa-miR-375 Sanger Database
NACRES:
NA.55

形式

liquid

浓度

10 mg/mL

成熟序列

UUUGUUCGUUCGGCUCGCGUGA

mp

~77.5 °C

Sanger mature/minor 登记号

MIMAT0000728

运输

wet ice

储存温度

−20°C

基因信息

human ... MIR375(494324)

相关类别

一般描述

The MystiCq® microRNA qPCR Assay Primer is an integral part of the MystiCq microRNA qPCR Assay System. It has been designed to target specific microRNAs with the MystiCq Universal PCR primer and the MystiCq® microRNA SYBR® Green qPCR ReadyMix™ on cDNA templates generated by the MystiCq microRNA cDNA Synthesis Mix kit.

特点和优势

  • Proprietary design features of assay primers allow for specificity towards mature microRNAs vs. precursor-microRNAs
  • Extensive design and testing of oligo-dT adapter primer to incorporate complementary Universal PCR Primer sequence
  • No self-complementarity or primer dimer artifacts with the Universal PCR Primer
  • Optimized primer Tm designed to match the Universal PCR Primer
  • Universal cycling conditions ensures robust amplification for all assays in profiling experiments
  • Optimized PCR product Tm (75-78° C)

其他说明

Compatible with mmu-miR-375 and rno-miR-375.

法律信息

MystiCq is a registered trademark of QIAGEN Beverly Inc.
ReadyMix is a trademark of Sigma-Aldrich Co. LLC
SYBR is a registered trademark of Life Technologies

WGK

WGK 1

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Ann-Christin Frank et al.
Theranostics, 11(15), 7570-7588 (2021-06-24)
Background: Glucose metabolism in the tumor-microenvironment is a fundamental hallmark for tumor growth and intervention therein remains an attractive option for anti-tumor therapy. Whether tumor-derived factors such as microRNAs (miRs) regulate glucose metabolism in stromal cells, especially in tumor-associated macrophages
A Mukherjee et al.
Andrology, 3(5), 979-990 (2015-08-28)
Mechanistic target of rapamycin (mTOR) is a signal transduction pathway that modulates translation initiation in several animals including mammals. Rapamaycin, an allosteric inhibitor of mTOR pathway, is often used as an immunosuppressive drug following kidney transplantation and causes gonadal dysfunction

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门